Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States
UPLIFT
1 other identifier
observational
1,150
1 country
11
Brief Summary
IMPAACT 2046/UPLIFT (Understanding Practices of Lactation and Infant Feeding decisions Together with women with HIV) is a multi-site, mixed-methods, observational cohort study. The purpose of the study is to explore infant feeding preferences, practices, and outcomes among mothers with HIV and their families in the United States. It will employ both qualitative and quantitative research methods to address existing knowledge gaps and to understand the clinical, behavioral, and social factors influencing infant feeding decisions. As part of the study's mixed method approach, a longitudinal cohort study of mothers and their infants will be established. The study also aims to pilot a national registry of breastfeeding women living with HIV in the United States.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2026
Longer than P75 for all trials
11 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 16, 2025
CompletedFirst Posted
Study publicly available on registry
December 19, 2025
CompletedStudy Start
First participant enrolled
February 24, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 24, 2031
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 24, 2031
March 27, 2026
March 1, 2026
5.2 years
December 16, 2025
March 25, 2026
Conditions
Outcome Measures
Primary Outcomes (12)
CA 1: Factors influencing infant feeding decision
Qualitative themes from in-depth interviews
Within 28 days and 2 years of Enrollment
CA 1: Infants born to women with HIV who receive any breast milk
Binomial outcome from site level surveys
Monthly, through study completion, up until 5 years
CA 2: Infant feeding method chosen
Binary outcome
At 48 weeks post birth
CA 2: Breastfeeding initiation among those who intended to breastfeed
Binary outcome
At 48 weeks post birth
CA 2: Duration of breastfeeding among PPWH who breastfeed
Numerical outcome
Through 96 weeks post birth
CA 2: Completion of intended duration of breastfeeding
Binary outcome
Through 96 weeks post birth
CA 2: Mixed method analysis of infant feeding practices from in-depth interviews and survey data
Descriptive joint display table, with qualitative key themes and quantitative findings
At 48 weeks post birth
CA 2: Breast milk samples with detectable HIV DNA or RNA
Binary outcome
Through 48 weeks post birth; At weaning up to 96 weeks post birth
CA 2: Viral load measured in different breast milk compartments
Numerical outcome
Through 48 weeks post birth; At weaning up to 96 weeks post birth
CA 3: Data completed in registry
Binary outcome; whether specified percentage of data is completed in registry
Through study completion, an average of 3 years
CA 3: Median score on Feasibility of Intervention Measure, Acceptability of Intervention Measure and Appropriateness of Intervention Measures
Numerical outcome
Through study completion, an average of 3 years
CA 3: Completion of two visit entries for at least three eligible participants
Binary outcome; whether sites complete entries
Through study completion, an average of 3 years
Secondary Outcomes (12)
CA 1: Approaches to support infant feeding decisions and improve quality of care
Within 28 days and 2 years of Enrollment
CA 1: Descriptive results of current practices, burden, benefits and resources
Monthly, through study completion, up to 5 years
CA 2: Median cost per postpartum woman with HIV and infant pair
Through study completion, up to 5 years
CA 2: Cost effectiveness ratio presented as cost per quality adjusted life year saved in breastfeeding mother/infant pair
Through study completion, up to 5 years
CA 2: Cost per case of medical condition prevented by breastfeeding
Through study completion, up to 5 years
- +7 more secondary outcomes
Study Arms (3)
Core Activity 1
This core activity aims to explore current site-level infant feeding practices and infant feeding decision-making and preferences at selected sites in the US.
Core Activity 2
This core activity aims to examine infant feeding practices and outcomes among women with HIV at selected sites in the US and to describe the financial implications of different infant feeding choices.
Core Activity 3
This core activity aims to pilot and assess the feasibility and acceptability of a national registry of breastfeeding women with HIV in the US.
Interventions
None; No intervention provided in this study
Eligibility Criteria
Pregnant and postpartum women with HIV (PPWH); healthcare providers (HCP) and ancillary healthcare professionals (AHP) who care for PPWH and/or their infants; other influential individuals who contribute to infant feeding decisions. Pilot registry testers who will enter data into the pilot registry.
You may qualify if:
- Is of legal age or circumstance to provide independent informed consent
- Belongs to one of the following five categories:
- Is pregnant with a gestational age of 28 0/7 to 37 6/7 weeks at entry and is considering breastfeeding
- Is pregnant with a gestational age of 28 0/7 to 37 6/7 weeks at entry and is not considering breastfeeding
- Gave birth to a live born infant after 28 February 2023, is over 4 weeks postpartum, did not breastfeed for any duration and has no intent to breastfeed
- Gave birth to a live born infant after 28 February 2023, is over 4 weeks postpartum, breastfed for less than four weeks, and has weaned
- Gave birth to a live born infant after 28 February 2023, is over 4 weeks postpartum, and breastfed for four weeks or longer
- Diagnosed with HIV prior to or during the pregnancy
- If preferred language is other than English, is willing to participate in interviews with an available translator.
- Is of legal age or circumstance to provide independent informed consent
- Is a healthcare provider who self-identifies as an obstetrician, midwife, nurse, adult or pediatric infectious disease specialist, or advance practice provider who participated in the care of at least five PPWH and/or their infants over the three years prior to entry OR
- Is an ancillary healthcare professional who self-identifies as a social worker, lactation support provider, patient navigator, pharmacist, doula who participated in the care of at least five PPWH and/or their infants over the three years prior to entry
- Has been identified by a PPWH enrolled in Core Activity 1 as aware of her HIV status and contributing to her infant feeding decisions
- Is of legal age or circumstance to provide independent informed consent
- If preferred language is other than English, is willing to participate in interviews with an available translator.
- +11 more criteria
You may not qualify if:
- Has any condition identified during the screening period that, in the opinion of site investigator, would preclude informed consent, make study participation unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Colorado, Denvercollaborator
- Centers for Disease Control and Preventioncollaborator
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)collaborator
- National Institute of Allergy and Infectious Diseases (NIAID)collaborator
- International Maternal Pediatric Adolescent AIDS Clinical Trials Grouplead
Study Sites (11)
University of Southern California (CRS 5048)
Los Angeles, California, 90089, United States
David Geffen School of Medicine at UCLA (CRS 5112)
Los Angeles, California, 90095, United States
University California, San Diego (CRS 4601)
San Diego, California, 92103, United States
University of Colorado, Denver (CRS 5052)
Aurora, Colorado, 80045, United States
University of Florida (5051)
Jacksonville, Florida, 32209, United States
Univ of Miami Pediatric/Perinatal HIV/AIDS (5127)
Miami, Florida, 33136, United States
5030, Emory University School of Medicine Clinical Research Site
Atlanta, Georgia, 30322, United States
Lurie Children's Hospital of Chicago (CRS 4001)
Chicago, Illinois, 60614, United States
Johns Hopkins University (CRS 5092)
Baltimore, Maryland, 21287, United States
Jacobi Med. Ctr. Bronx NICHD CRS (5013)
The Bronx, New York, 10461, United States
St. Jude Childrens Research Hosp, Memphis (6501)
Memphis, Tennessee, 38105, United States
Biospecimen
Core Activity 2 participants will be asked whether they agree to storage and future research testing of breastmilk specimens. Human genetic testing of leftover specimens is optional and may be declined.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Lisa Abuogi
University of Colorado, Denver
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 16, 2025
First Posted
December 19, 2025
Study Start
February 24, 2026
Primary Completion (Estimated)
April 24, 2031
Study Completion (Estimated)
April 24, 2031
Last Updated
March 27, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Beginning 3 months following publication and available throughout period of funding of the International Maternal Pediatric Adolescent AIDS Clinical Trial (IMPAACT)
- Access Criteria
- * With whom? Researchers who provide a methodologically sound proposal for use of the data that is approved by the IMPAACT Network and CDC. * For what types of analyses? To achieve aims in the proposal approved by the IMPAACT Network and CDC. * By what mechanism will data be made available? Researchers may submit a request for access to data using the IMPAACT "Data Request" form at: https://www.impaactnetwork.org/studies/submit-research-proposal. Researchers of approved proposals will need to sign an IMPAACT Data Use Agreement before receiving the data.
Individual participant data that underlie results in the publication, after deidentification.